Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 CYSLTR1 1件: Neuroactive ligand-receptor interaction D01385 Ibudilast 2件: 2, 13
2 CYSLTR1 1件: Neuroactive ligand-receptor interaction D06659 Tipelukast 1件: 85
3 CYSLTR1 1件: Neuroactive ligand-receptor interaction D08229 Montelukast 8件: 6, 13, 46, 61, 63, 85, 98, 228
4 HRH3 1件: Neuroactive ligand-receptor interaction D09870 Bavisant 1件: 6
5 HRH3 1件: Neuroactive ligand-receptor interaction D10749 Pitolisant 3件: 6, 113, 193
6 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00113 Atropine 2件: 2, 299
7 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00138 Scopolamine 1件: 2
8 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00270 Chlorpromazine 1件: 254
9 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00397 Tropicamide 1件: 6
10 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00465 Oxybutynin 3件: 6, 13, 53
11 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08441 Propiverine 1件: 226
12 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08638 Trihexyphenidyl 2件: 5, 6
13 CHRM1 4件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D11383 Blarcamesine 1件: 156
14 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00113 Atropine 2件: 2, 299
15 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00138 Scopolamine 1件: 2
16 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00270 Chlorpromazine 1件: 254
17 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00397 Tropicamide 1件: 6
18 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00465 Oxybutynin 3件: 6, 13, 53
19 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D00525 Pilocarpine 3件: 6, 53, 299
20 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D07226 Fesoterodine 1件: 6
21 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08441 Propiverine 1件: 226
22 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D08638 Trihexyphenidyl 2件: 5, 6
23 CHRM2 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton D11383 Blarcamesine 1件: 156
24 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D00113 Atropine 2件: 2, 299
25 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D00138 Scopolamine 1件: 2
26 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D00270 Chlorpromazine 1件: 254
27 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D00397 Tropicamide 1件: 6
28 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D00465 Oxybutynin 3件: 6, 13, 53
29 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D00525 Pilocarpine 3件: 6, 53, 299
30 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D00646 Tolterodine 2件: 17, 53
31 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D03654 Darifenacin 2件: 6, 13
32 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D07226 Fesoterodine 1件: 6
33 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D07667 Cevimeline 1件: 53
34 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D08441 Propiverine 1件: 226
35 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D08522 Solifenacin 3件: 6, 13, 53
36 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D08638 Trihexyphenidyl 2件: 5, 6
37 CHRM3 6件: Neuroactive ligand-receptor interaction, Taste transduction, Regulation of actin cytoskeleton, Salivary secretion, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases D11383 Blarcamesine 1件: 156
38 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D00113 Atropine 2件: 2, 299
39 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D00138 Scopolamine 1件: 2
40 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D00270 Chlorpromazine 1件: 254
41 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D00397 Tropicamide 1件: 6
42 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D00465 Oxybutynin 3件: 6, 13, 53
43 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D08441 Propiverine 1件: 226
44 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D08638 Trihexyphenidyl 2件: 5, 6
45 CHRM4 2件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton D11383 Blarcamesine 1件: 156
46 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00113 Atropine 2件: 2, 299
47 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00138 Scopolamine 1件: 2
48 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00270 Chlorpromazine 1件: 254
49 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00397 Tropicamide 1件: 6
50 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D00465 Oxybutynin 3件: 6, 13, 53
51 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08441 Propiverine 1件: 226
52 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D08638 Trihexyphenidyl 2件: 5, 6
53 CHRM5 3件: Neuroactive ligand-receptor interaction, Regulation of actin cytoskeleton, Pathways of neurodegeneration - multiple diseases D11383 Blarcamesine 1件: 156
54 CHRNA1 2件: Virion - Lyssavirus, Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
55 CHRNA2 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
56 CHRNA3 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
57 CHRNA4 2件: Neuroactive ligand-receptor interaction, Nicotine addiction D03365 Nicotine 3件: 6, 13, 84
58 CHRNA4 2件: Neuroactive ligand-receptor interaction, Nicotine addiction D08669 Varenicline 3件: 6, 18, 53
59 CHRNA5 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
60 CHRNA7 3件: Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D03365 Nicotine 3件: 6, 13, 84
61 CHRNB1 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
62 CHRNB2 2件: Neuroactive ligand-receptor interaction, Nicotine addiction D03365 Nicotine 3件: 6, 13, 84
63 CHRNB2 2件: Neuroactive ligand-receptor interaction, Nicotine addiction D08669 Varenicline 3件: 6, 18, 53
64 CHRNB3 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
65 CHRNB4 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
66 CHRND 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
67 CHRNE 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
68 CHRNG 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
69 CNR1 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling D00306 Dronabinol 8件: 2, 8, 13, 36, 46, 96, 271, 298
70 CNR1 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling D05099 Nabilone 3件: 6, 13, 127
71 CNR1 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling D05731 Rimonabant 1件: 193
72 CNR1 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Retrograde endocannabinoid signaling D10915 Cannabidiol 20件: 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
73 CNR2 1件: Neuroactive ligand-receptor interaction D00306 Dronabinol 8件: 2, 8, 13, 36, 46, 96, 271, 298
74 CNR2 1件: Neuroactive ligand-receptor interaction D05099 Nabilone 3件: 6, 13, 127
75 CNR2 1件: Neuroactive ligand-receptor interaction D10915 Cannabidiol 20件: 2, 6, 8, 13, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271
76 CNR2 1件: Neuroactive ligand-receptor interaction D11312 Ajulemic acid 3件: 50, 51, 299
77 ADORA1 4件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion D00045 Adenosine 3件: 13, 58, 65
78 ADORA1 4件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion D00227 Aminophylline 1件: 63
79 ADORA1 4件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion D00371 Theophylline 2件: 236, 299
80 ADORA1 4件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
81 ADORA1 4件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
82 ADORA1 4件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion D02769 Adenosine phosphate 1件: 46
83 ADORA1 4件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion D06103 Theophylline 2件: 236, 299
84 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D00045 Adenosine 3件: 13, 58, 65
85 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D00528 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
86 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D01453 Caffeine 8件: 2, 6, 21, 46, 78, 96, 97, 265
87 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D02769 Adenosine phosphate 1件: 46
88 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D04641 Istradefylline 1件: 6
89 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D05711 Regadenoson 1件: 58
90 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D09717 Preladenant 1件: 6
91 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D10174 Tozadenant 1件: 6
92 ADORA2A 4件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson disease D12568 Regadenoson 1件: 58
93 ADORA2B 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D00045 Adenosine 3件: 13, 58, 65
94 ADORA2B 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D00227 Aminophylline 1件: 63
95 ADORA2B 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D00371 Theophylline 2件: 236, 299
96 ADORA2B 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D02769 Adenosine phosphate 1件: 46
97 ADORA2B 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D06103 Theophylline 2件: 236, 299
98 CRHR1 1件: Neuroactive ligand-receptor interaction D03592 Corticorelin ovine triflutate 1件: 75
99 CRHR1 1件: Neuroactive ligand-receptor interaction D03905 Corticorelin 1件: 75
100 CRHR2 1件: Neuroactive ligand-receptor interaction D03592 Corticorelin ovine triflutate 1件: 75
101 CRHR2 1件: Neuroactive ligand-receptor interaction D03905 Corticorelin 1件: 75
102 ADORA3 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D00045 Adenosine 3件: 13, 58, 65
103 ADORA3 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D02769 Adenosine phosphate 1件: 46
104 ADORA3 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10971 Piclidenoson 1件: 46
105 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00076 Norepinephrine 2件: 22, 296
106 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00095 Epinephrine 3件: 46, 70, 96
107 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00124 Ephedrine 1件: 11
108 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00255 Carvedilol 4件: 57, 86, 113, 210
109 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00454 Olanzapine 2件: 2, 8
110 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D01277 Droxidopa 5件: 5, 6, 17, 169, 170
111 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D02349 Dipivefrin 1件: 6
112 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D02910 Amiodarone 2件: 28, 127
113 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D07874 Doxazosin 2件: 57, 67
114 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08207 Methylergometrine 1件: 280
115 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08220 Midodrine 3件: 6, 17, 58
116 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08365 Phenylephrine 1件: 22
117 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08449 Pseudoephedrine 1件: 17
118 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08560 Tamsulosin 1件: 13
119 ADRA1D 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08569 Terazosin 1件: 6
120 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00076 Norepinephrine 2件: 22, 296
121 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00095 Epinephrine 3件: 46, 70, 96
122 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00124 Ephedrine 1件: 11
123 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00255 Carvedilol 4件: 57, 86, 113, 210
124 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00454 Olanzapine 2件: 2, 8
125 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D01277 Droxidopa 5件: 5, 6, 17, 169, 170
126 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D02349 Dipivefrin 1件: 6
127 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D02910 Amiodarone 2件: 28, 127
128 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D07874 Doxazosin 2件: 57, 67
129 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08207 Methylergometrine 1件: 280
130 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08220 Midodrine 3件: 6, 17, 58
131 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08365 Phenylephrine 1件: 22
132 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08449 Pseudoephedrine 1件: 17
133 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08560 Tamsulosin 1件: 13
134 ADRA1B 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08569 Terazosin 1件: 6
135 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00076 Norepinephrine 2件: 22, 296
136 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00095 Epinephrine 3件: 46, 70, 96
137 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00124 Ephedrine 1件: 11
138 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00255 Carvedilol 4件: 57, 86, 113, 210
139 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D00454 Olanzapine 2件: 2, 8
140 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D01277 Droxidopa 5件: 5, 6, 17, 169, 170
141 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D01965 Silodosin 2件: 6, 13
142 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D02349 Dipivefrin 1件: 6
143 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D02910 Amiodarone 2件: 28, 127
144 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D07124 Alfuzosin 1件: 13
145 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D07874 Doxazosin 2件: 57, 67
146 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08207 Methylergometrine 1件: 280
147 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08220 Midodrine 3件: 6, 17, 58
148 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08365 Phenylephrine 1件: 22
149 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08449 Pseudoephedrine 1件: 17
150 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08560 Tamsulosin 1件: 13
151 ADRA1A 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Salivary secretion D08569 Terazosin 1件: 6
152 ADRA2A 1件: Neuroactive ligand-receptor interaction D00076 Norepinephrine 2件: 22, 296
153 ADRA2A 1件: Neuroactive ligand-receptor interaction D00095 Epinephrine 3件: 46, 70, 96
154 ADRA2A 1件: Neuroactive ligand-receptor interaction D00124 Ephedrine 1件: 11
155 ADRA2A 1件: Neuroactive ligand-receptor interaction D00270 Chlorpromazine 1件: 254
156 ADRA2A 1件: Neuroactive ligand-receptor interaction D00281 Clonidine 4件: 6, 65, 70, 78
157 ADRA2A 1件: Neuroactive ligand-receptor interaction D00283 Clozapine 1件: 6
158 ADRA2A 1件: Neuroactive ligand-receptor interaction D00514 Dexmedetomidine 14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280
159 ADRA2A 1件: Neuroactive ligand-receptor interaction D00560 Pimozide 1件: 2
160 ADRA2A 1件: Neuroactive ligand-receptor interaction D01277 Droxidopa 5件: 5, 6, 17, 169, 170
161 ADRA2A 1件: Neuroactive ligand-receptor interaction D02349 Dipivefrin 1件: 6
162 ADRA2A 1件: Neuroactive ligand-receptor interaction D04375 Guanabenz 2件: 2, 13
163 ADRA2A 1件: Neuroactive ligand-receptor interaction D07461 Apraclonidine 1件: 11
164 ADRA2A 1件: Neuroactive ligand-receptor interaction D07540 Brimonidine 2件: 13, 90
165 ADRA2A 1件: Neuroactive ligand-receptor interaction D08031 Guanfacine 1件: 193
166 ADRA2A 1件: Neuroactive ligand-receptor interaction D08207 Methylergometrine 1件: 280
167 ADRA2A 1件: Neuroactive ligand-receptor interaction D08449 Pseudoephedrine 1件: 17
168 ADRA2A 1件: Neuroactive ligand-receptor interaction D08482 Rilmenidine 1件: 8
169 ADRA2A 1件: Neuroactive ligand-receptor interaction D08611 Tizanidine 1件: 13
170 ADRA2A 1件: Neuroactive ligand-receptor interaction D08685 Yohimbine 1件: 6
171 ADRA2B 1件: Neuroactive ligand-receptor interaction D00076 Norepinephrine 2件: 22, 296
172 ADRA2B 1件: Neuroactive ligand-receptor interaction D00095 Epinephrine 3件: 46, 70, 96
173 ADRA2B 1件: Neuroactive ligand-receptor interaction D00124 Ephedrine 1件: 11
174 ADRA2B 1件: Neuroactive ligand-receptor interaction D00270 Chlorpromazine 1件: 254
175 ADRA2B 1件: Neuroactive ligand-receptor interaction D00281 Clonidine 4件: 6, 65, 70, 78
176 ADRA2B 1件: Neuroactive ligand-receptor interaction D00283 Clozapine 1件: 6
177 ADRA2B 1件: Neuroactive ligand-receptor interaction D00514 Dexmedetomidine 14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280
178 ADRA2B 1件: Neuroactive ligand-receptor interaction D01277 Droxidopa 5件: 5, 6, 17, 169, 170
179 ADRA2B 1件: Neuroactive ligand-receptor interaction D02349 Dipivefrin 1件: 6
180 ADRA2B 1件: Neuroactive ligand-receptor interaction D04375 Guanabenz 2件: 2, 13
181 ADRA2B 1件: Neuroactive ligand-receptor interaction D07461 Apraclonidine 1件: 11
182 ADRA2B 1件: Neuroactive ligand-receptor interaction D07540 Brimonidine 2件: 13, 90
183 ADRA2B 1件: Neuroactive ligand-receptor interaction D08207 Methylergometrine 1件: 280
184 ADRA2B 1件: Neuroactive ligand-receptor interaction D08449 Pseudoephedrine 1件: 17
185 ADRA2B 1件: Neuroactive ligand-receptor interaction D08482 Rilmenidine 1件: 8
186 ADRA2B 1件: Neuroactive ligand-receptor interaction D08611 Tizanidine 1件: 13
187 ADRA2B 1件: Neuroactive ligand-receptor interaction D08685 Yohimbine 1件: 6
188 ADRA2C 1件: Neuroactive ligand-receptor interaction D00076 Norepinephrine 2件: 22, 296
189 ADRA2C 1件: Neuroactive ligand-receptor interaction D00095 Epinephrine 3件: 46, 70, 96
190 ADRA2C 1件: Neuroactive ligand-receptor interaction D00124 Ephedrine 1件: 11
191 ADRA2C 1件: Neuroactive ligand-receptor interaction D00270 Chlorpromazine 1件: 254
192 ADRA2C 1件: Neuroactive ligand-receptor interaction D00281 Clonidine 4件: 6, 65, 70, 78
193 ADRA2C 1件: Neuroactive ligand-receptor interaction D00283 Clozapine 1件: 6
194 ADRA2C 1件: Neuroactive ligand-receptor interaction D00514 Dexmedetomidine 14件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280
195 ADRA2C 1件: Neuroactive ligand-receptor interaction D01277 Droxidopa 5件: 5, 6, 17, 169, 170
196 ADRA2C 1件: Neuroactive ligand-receptor interaction D02349 Dipivefrin 1件: 6
197 ADRA2C 1件: Neuroactive ligand-receptor interaction D04375 Guanabenz 2件: 2, 13
198 ADRA2C 1件: Neuroactive ligand-receptor interaction D07461 Apraclonidine 1件: 11
199 ADRA2C 1件: Neuroactive ligand-receptor interaction D07540 Brimonidine 2件: 13, 90
200 ADRA2C 1件: Neuroactive ligand-receptor interaction D08207 Methylergometrine 1件: 280
201 ADRA2C 1件: Neuroactive ligand-receptor interaction D08449 Pseudoephedrine 1件: 17
202 ADRA2C 1件: Neuroactive ligand-receptor interaction D08482 Rilmenidine 1件: 8
203 ADRA2C 1件: Neuroactive ligand-receptor interaction D08611 Tizanidine 1件: 13
204 ADRA2C 1件: Neuroactive ligand-receptor interaction D08685 Yohimbine 1件: 6
205 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00076 Norepinephrine 2件: 22, 296
206 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00095 Epinephrine 3件: 46, 70, 96
207 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00124 Ephedrine 1件: 11
208 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00235 Atenolol 1件: 167
209 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00255 Carvedilol 4件: 57, 86, 113, 210
210 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00378 Timolol 2件: 157, 227
211 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00432 Nadolol 1件: 6
212 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D01277 Droxidopa 5件: 5, 6, 17, 169, 170
213 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02342 Bisoprolol 4件: 58, 67, 86, 113
214 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02349 Dipivefrin 1件: 6
215 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02358 Metoprolol 6件: 17, 57, 58, 113, 193, 226
216 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02910 Amiodarone 2件: 28, 127
217 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D03879 Dobutamine 4件: 57, 58, 86, 215
218 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D05127 Nebivolol 4件: 17, 85, 113, 167
219 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D07660 Celiprolol 1件: 168
220 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D07916 Esmolol 1件: 58
221 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08443 Propranolol 6件: 6, 158, 167, 227, 278, 296
222 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08449 Pseudoephedrine 1件: 17
223 ADRB1 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08600 Timolol 2件: 157, 227
224 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00076 Norepinephrine 2件: 22, 296
225 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00095 Epinephrine 3件: 46, 70, 96
226 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00124 Ephedrine 1件: 11
227 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00255 Carvedilol 4件: 57, 86, 113, 210
228 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00378 Timolol 2件: 157, 227
229 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00432 Nadolol 1件: 6
230 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D01277 Droxidopa 5件: 5, 6, 17, 169, 170
231 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02147 Salbutamol 12件: 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299
232 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02151 Tulobuterol 1件: 6
233 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02349 Dipivefrin 1件: 6
234 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D05792 Salmeterol 1件: 299
235 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D07713 Clenbuterol 5件: 1, 2, 6, 13, 256
236 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D07990 Formoterol 3件: 85, 228, 299
237 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08092 Isoxsuprine 1件: 13
238 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08124 Levosalbutamol 1件: 49
239 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08443 Propranolol 6件: 6, 158, 167, 227, 278, 296
240 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08449 Pseudoephedrine 1件: 17
241 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08570 Terbutaline 1件: 118
242 ADRB2 4件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08600 Timolol 2件: 157, 227
243 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00076 Norepinephrine 2件: 22, 296
244 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00095 Epinephrine 3件: 46, 70, 96
245 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D00124 Ephedrine 1件: 11
246 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D01277 Droxidopa 5件: 5, 6, 17, 169, 170
247 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D02349 Dipivefrin 1件: 6
248 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08443 Propranolol 6件: 6, 158, 167, 227, 278, 296
249 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D08449 Pseudoephedrine 1件: 17
250 ADRB3 5件: Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion D09535 Mirabegron 4件: 6, 13, 53, 226
251 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D00059 Levodopa 6件: 6, 17, 90, 140, 164, 201
252 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D01044 Flupentixol 1件: 97
253 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D07460 Apomorphine 3件: 5, 6, 7
254 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D07870 Dopamine 4件: 6, 7, 74, 299
255 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D08339 Pergolide 1件: 6
256 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D09886 Dexpramipexole 1件: 2
257 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D11431 Tavapadon 1件: 6
258 DRD1 2件: Neuroactive ligand-receptor interaction, Parkinson disease D11839 Foslevodopa 1件: 6
259 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00059 Levodopa 6件: 6, 17, 90, 140, 164, 201
260 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00136 Haloperidol 1件: 8
261 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00270 Chlorpromazine 1件: 254
262 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00426 Risperidone 5件: 8, 156, 179, 187, 206
263 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00454 Olanzapine 2件: 2, 8
264 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00560 Pimozide 1件: 2
265 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00726 Metoclopramide 2件: 46, 51
266 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D00987 Cabergoline 3件: 6, 74, 75
267 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D01044 Flupentixol 1件: 97
268 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D01164 Aripiprazole 2件: 6, 206
269 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D01226 Sulpiride 2件: 6, 70
270 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D01348 Terguride 2件: 51, 86
271 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D01448 Trifluoperazine 2件: 283, 284
272 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D01745 Domperidone 5件: 6, 13, 17, 51, 230
273 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D02666 Iloperidone 1件: 6
274 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D03165 Bromocriptine 2件: 6, 74
275 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D05575 Pramipexole 3件: 2, 6, 20
276 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D05768 Rotigotine 1件: 6
277 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D07305 Piribedil 1件: 6
278 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D07309 Melperone 1件: 6
279 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D07460 Apomorphine 3件: 5, 6, 7
280 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D07593 Buspirone 2件: 6, 51
281 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D07868 Domperidone 5件: 6, 13, 17, 51, 230
282 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D07870 Dopamine 4件: 6, 7, 74, 299
283 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D08132 Lisuride 2件: 6, 86
284 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D08339 Pergolide 1件: 6
285 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D08456 Quetiapine 2件: 6, 13
286 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D08489 Ropinirole 4件: 2, 6, 74, 309
287 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D08590 Tiapride 1件: 8
288 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D08636 Trifluoperazine 2件: 283, 284
289 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D09397 Pardoprunox 1件: 6
290 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D09886 Dexpramipexole 1件: 2
291 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D09953 Pridopidine 3件: 2, 6, 8
292 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D09997 Cariprazine 1件: 21
293 DRD2 3件: Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease D11839 Foslevodopa 1件: 6
294 DRD3 1件: Neuroactive ligand-receptor interaction D00059 Levodopa 6件: 6, 17, 90, 140, 164, 201
295 DRD3 1件: Neuroactive ligand-receptor interaction D00454 Olanzapine 2件: 2, 8
296 DRD3 1件: Neuroactive ligand-receptor interaction D01164 Aripiprazole 2件: 6, 206
297 DRD3 1件: Neuroactive ligand-receptor interaction D05575 Pramipexole 3件: 2, 6, 20
298 DRD3 1件: Neuroactive ligand-receptor interaction D07305 Piribedil 1件: 6
299 DRD3 1件: Neuroactive ligand-receptor interaction D07870 Dopamine 4件: 6, 7, 74, 299
300 DRD3 1件: Neuroactive ligand-receptor interaction D08132 Lisuride 2件: 6, 86
301 DRD3 1件: Neuroactive ligand-receptor interaction D08489 Ropinirole 4件: 2, 6, 74, 309
302 DRD3 1件: Neuroactive ligand-receptor interaction D09397 Pardoprunox 1件: 6
303 DRD3 1件: Neuroactive ligand-receptor interaction D09886 Dexpramipexole 1件: 2
304 DRD3 1件: Neuroactive ligand-receptor interaction D11839 Foslevodopa 1件: 6
305 DRD4 1件: Neuroactive ligand-receptor interaction D00059 Levodopa 6件: 6, 17, 90, 140, 164, 201
306 DRD4 1件: Neuroactive ligand-receptor interaction D00283 Clozapine 1件: 6
307 DRD4 1件: Neuroactive ligand-receptor interaction D00454 Olanzapine 2件: 2, 8
308 DRD4 1件: Neuroactive ligand-receptor interaction D05575 Pramipexole 3件: 2, 6, 20
309 DRD4 1件: Neuroactive ligand-receptor interaction D07870 Dopamine 4件: 6, 7, 74, 299
310 DRD4 1件: Neuroactive ligand-receptor interaction D08132 Lisuride 2件: 6, 86
311 DRD4 1件: Neuroactive ligand-receptor interaction D08489 Ropinirole 4件: 2, 6, 74, 309
312 DRD4 1件: Neuroactive ligand-receptor interaction D09886 Dexpramipexole 1件: 2
313 DRD4 1件: Neuroactive ligand-receptor interaction D11839 Foslevodopa 1件: 6
314 DRD5 1件: Neuroactive ligand-receptor interaction D00059 Levodopa 6件: 6, 17, 90, 140, 164, 201
315 DRD5 1件: Neuroactive ligand-receptor interaction D07870 Dopamine 4件: 6, 7, 74, 299
316 DRD5 1件: Neuroactive ligand-receptor interaction D09886 Dexpramipexole 1件: 2
317 DRD5 1件: Neuroactive ligand-receptor interaction D11431 Tavapadon 1件: 6
318 DRD5 1件: Neuroactive ligand-receptor interaction D11839 Foslevodopa 1件: 6
319 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00150 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224
320 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00400 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224
321 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00522 Candesartan 2件: 58, 67
322 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00523 Irbesartan 4件: 66, 167, 168, 222
323 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00626 Candesartan cilexetil 1件: 67
324 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00627 Telmisartan 2件: 66, 67
325 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D02014 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224
326 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D08146 Losartan 17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
327 AGTR1 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D11776 Sparsentan 3件: 66, 218, 222
328 AGTR2 2件: Neuroactive ligand-receptor interaction, Renin-angiotensin system D00150 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224
329 AGTR2 2件: Neuroactive ligand-receptor interaction, Renin-angiotensin system D02014 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224
330 S1PR1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10001 Fingolimod 3件: 13, 14, 156
331 S1PR1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10905 Amiselimod 1件: 97
332 S1PR1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10930 Etrasimod 3件: 96, 97, 98
333 S1PR1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10968 Ozanimod 3件: 13, 96, 97
334 S1PR1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D11215 Ponesimod 1件: 13
335 S1PR1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D11283 Cenerimod 1件: 49
336 S1PR1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D11460 Siponimod 2件: 13, 50
337 S1PR3 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10905 Amiselimod 1件: 97
338 S1PR3 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10930 Etrasimod 3件: 96, 97, 98
339 S1PR3 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10968 Ozanimod 3件: 13, 96, 97
340 EDNRA 4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D01227 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
341 EDNRA 4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07077 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211
342 EDNRA 4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07171 Sitaxentan 1件: 86
343 EDNRA 4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07538 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
344 EDNRA 4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07741 Zibotentan 1件: 51
345 EDNRA 4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D10135 Macitentan 5件: 51, 85, 86, 88, 210
346 EDNRA 4件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D11776 Sparsentan 3件: 66, 218, 222
347 EDNRB 3件: Neuroactive ligand-receptor interaction, Relaxin signaling pathway, Pathways in cancer D01227 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
348 EDNRB 3件: Neuroactive ligand-receptor interaction, Relaxin signaling pathway, Pathways in cancer D07538 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
349 EDNRB 3件: Neuroactive ligand-receptor interaction, Relaxin signaling pathway, Pathways in cancer D10135 Macitentan 5件: 51, 85, 86, 88, 210
350 F2 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Pathways in cancer D06410 Thrombomodulin Alfa 1件: 85
351 F2 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Pathways in cancer D07144 Dabigatran etexilate 2件: 51, 75
352 F2 6件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation, Regulation of actin cytoskeleton, Pathogenic Escherichia coli infection, Pathways in cancer D09707 Dabigatran 5件: 51, 75, 85, 91, 124
353 GABBR1 2件: Neuroactive ligand-receptor interaction, Taste transduction D00241 Baclofen 8件: 2, 10, 13, 18, 65, 70, 149, 206
354 GABBR1 2件: Neuroactive ligand-receptor interaction, Taste transduction D08861 Arbaclofen Placarbil 1件: 13
355 GABBR1 2件: Neuroactive ligand-receptor interaction, Taste transduction D09791 Arbaclofen 2件: 13, 206
356 GABBR1 2件: Neuroactive ligand-receptor interaction, Taste transduction D12240 Valiloxybate 1件: 6
357 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00225 Alprazolam 2件: 8, 75
358 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00280 Clonazepam 1件: 6
359 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
360 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00365 Lorazepam 1件: 36
361 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
362 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00548 Etomidate 1件: 6
363 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
364 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
365 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
366 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01253 Clobazam 2件: 140, 144
367 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01372 Zopiclone 1件: 6
368 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
369 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
370 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
371 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
372 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
373 GABRA1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D11149 Brexanolone 1件: 205
374 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00225 Alprazolam 2件: 8, 75
375 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00280 Clonazepam 1件: 6
376 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
377 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00365 Lorazepam 1件: 36
378 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
379 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
380 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
381 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
382 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01253 Clobazam 2件: 140, 144
383 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01372 Zopiclone 1件: 6
384 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
385 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
386 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
387 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
388 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
389 GABRA2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D11149 Brexanolone 1件: 205
390 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00225 Alprazolam 2件: 8, 75
391 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00280 Clonazepam 1件: 6
392 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
393 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00365 Lorazepam 1件: 36
394 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
395 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
396 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
397 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
398 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01253 Clobazam 2件: 140, 144
399 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01372 Zopiclone 1件: 6
400 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
401 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
402 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
403 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
404 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
405 GABRA3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D11149 Brexanolone 1件: 205
406 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00225 Alprazolam 2件: 8, 75
407 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00280 Clonazepam 1件: 6
408 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
409 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00365 Lorazepam 1件: 36
410 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
411 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
412 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
413 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
414 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01253 Clobazam 2件: 140, 144
415 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01372 Zopiclone 1件: 6
416 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
417 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
418 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
419 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
420 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
421 GABRA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D11149 Brexanolone 1件: 205
422 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00225 Alprazolam 2件: 8, 75
423 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00280 Clonazepam 1件: 6
424 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
425 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00365 Lorazepam 1件: 36
426 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
427 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
428 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
429 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
430 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01253 Clobazam 2件: 140, 144
431 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01372 Zopiclone 1件: 6
432 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
433 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
434 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
435 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
436 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
437 GABRA5 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D11149 Brexanolone 1件: 205
438 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00225 Alprazolam 2件: 8, 75
439 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00280 Clonazepam 1件: 6
440 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
441 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00365 Lorazepam 1件: 36
442 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
443 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
444 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
445 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
446 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01253 Clobazam 2件: 140, 144
447 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D01372 Zopiclone 1件: 6
448 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
449 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
450 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
451 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
452 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
453 GABRA6 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Taste transduction, Nicotine addiction D11149 Brexanolone 1件: 205
454 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00225 Alprazolam 2件: 8, 75
455 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00280 Clonazepam 1件: 6
456 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
457 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00365 Lorazepam 1件: 36
458 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
459 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
460 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
461 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
462 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D01253 Clobazam 2件: 140, 144
463 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D01372 Zopiclone 1件: 6
464 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
465 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
466 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
467 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
468 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
469 GABRB1 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D11149 Brexanolone 1件: 205
470 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00225 Alprazolam 2件: 8, 75
471 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00280 Clonazepam 1件: 6
472 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
473 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00365 Lorazepam 1件: 36
474 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
475 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
476 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
477 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
478 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D01253 Clobazam 2件: 140, 144
479 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D01372 Zopiclone 1件: 6
480 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
481 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
482 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
483 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
484 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
485 GABRB2 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D11149 Brexanolone 1件: 205
486 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00225 Alprazolam 2件: 8, 75
487 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00280 Clonazepam 1件: 6
488 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
489 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00365 Lorazepam 1件: 36
490 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
491 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
492 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
493 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
494 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D01253 Clobazam 2件: 140, 144
495 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D01372 Zopiclone 1件: 6
496 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
497 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
498 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
499 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
500 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
501 GABRB3 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, Nicotine addiction D11149 Brexanolone 1件: 205
502 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00225 Alprazolam 2件: 8, 75
503 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00280 Clonazepam 1件: 6
504 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
505 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00365 Lorazepam 1件: 36
506 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
507 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
508 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
509 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
510 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01253 Clobazam 2件: 140, 144
511 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01372 Zopiclone 1件: 6
512 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
513 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
514 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
515 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
516 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
517 GABRD 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D11149 Brexanolone 1件: 205
518 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00225 Alprazolam 2件: 8, 75
519 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00280 Clonazepam 1件: 6
520 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
521 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00365 Lorazepam 1件: 36
522 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
523 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
524 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
525 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
526 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01253 Clobazam 2件: 140, 144
527 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01372 Zopiclone 1件: 6
528 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
529 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
530 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
531 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
532 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
533 GABRE 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D11149 Brexanolone 1件: 205
534 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00225 Alprazolam 2件: 8, 75
535 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00280 Clonazepam 1件: 6
536 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
537 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00365 Lorazepam 1件: 36
538 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
539 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
540 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
541 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
542 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01253 Clobazam 2件: 140, 144
543 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01372 Zopiclone 1件: 6
544 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
545 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
546 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
547 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
548 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
549 GABRG1 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D11149 Brexanolone 1件: 205
550 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00225 Alprazolam 2件: 8, 75
551 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00280 Clonazepam 1件: 6
552 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
553 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00365 Lorazepam 1件: 36
554 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
555 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
556 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
557 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
558 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01253 Clobazam 2件: 140, 144
559 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01372 Zopiclone 1件: 6
560 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
561 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
562 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
563 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
564 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
565 GABRG2 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D11149 Brexanolone 1件: 205
566 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00225 Alprazolam 2件: 8, 75
567 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00280 Clonazepam 1件: 6
568 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
569 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00365 Lorazepam 1件: 36
570 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
571 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
572 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
573 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
574 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01253 Clobazam 2件: 140, 144
575 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01372 Zopiclone 1件: 6
576 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
577 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
578 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
579 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
580 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
581 GABRG3 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D11149 Brexanolone 1件: 205
582 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00225 Alprazolam 2件: 8, 75
583 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00280 Clonazepam 1件: 6
584 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
585 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00365 Lorazepam 1件: 36
586 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
587 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
588 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
589 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
590 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01253 Clobazam 2件: 140, 144
591 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01372 Zopiclone 1件: 6
592 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
593 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
594 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
595 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
596 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
597 GABRP 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D11149 Brexanolone 1件: 205
598 GHR 2件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway D03297 Mecasermin 6件: 65, 78, 96, 168, 265, 299
599 GHR 2件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway D05394 Pegvisomant 2件: 78, 265
600 GHR 2件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway D11193 Somavaratan 1件: 78
601 GHR 2件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway D11194 Somapacitan 2件: 78, 195
602 GHR 2件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway D11486 Lonapegsomatropin 1件: 78
603 GHRHR 1件: Neuroactive ligand-receptor interaction D06655 Tesamorelin 2件: 78, 265
604 GHRHR 1件: Neuroactive ligand-receptor interaction D08523 Somatorelin 2件: 13, 78
605 GHSR 1件: Neuroactive ligand-receptor interaction D10563 Macimorelin 1件: 78
606 GIPR 1件: Neuroactive ligand-receptor interaction D11360 Tirzepatide 1件: 233
607 GLP1R 1件: Neuroactive ligand-receptor interaction D04121 Exenatide 6件: 6, 17, 72, 78, 193, 233
608 GLP1R 1件: Neuroactive ligand-receptor interaction D06404 Liraglutide 3件: 6, 75, 193
609 GLP1R 1件: Neuroactive ligand-receptor interaction D09729 Lixisenatide 1件: 6
610 GLP1R 1件: Neuroactive ligand-receptor interaction D09889 Dulaglutide 2件: 13, 299
611 GLP1R 1件: Neuroactive ligand-receptor interaction D10025 Semaglutide 1件: 6
612 GLP1R 1件: Neuroactive ligand-receptor interaction D11360 Tirzepatide 1件: 233
613 GNRHR 1件: Neuroactive ligand-receptor interaction D02369 Histrelin 1件: 76
614 GNRHR 1件: Neuroactive ligand-receptor interaction D04405 Goserelin 1件: 1
615 GNRHR 1件: Neuroactive ligand-receptor interaction D06247 Triptorelin 2件: 49, 76
616 GNRHR 1件: Neuroactive ligand-receptor interaction D07665 Cetrorelix 1件: 46
617 GNRHR 1件: Neuroactive ligand-receptor interaction D08027 Gonadorelin 1件: 76
618 GRIA1 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
619 GRIA1 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
620 GRIA1 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D02696 Talampanel 2件: 2, 6
621 GRIA1 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08964 Perampanel 3件: 2, 6, 144
622 GRIA2 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
623 GRIA2 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
624 GRIA2 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D02696 Talampanel 2件: 2, 6
625 GRIA2 5件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08964 Perampanel 3件: 2, 6, 144
626 GRIA3 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Transcriptional misregulation in cancer D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
627 GRIA3 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Transcriptional misregulation in cancer D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
628 GRIA3 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Transcriptional misregulation in cancer D02696 Talampanel 2件: 2, 6
629 GRIA3 6件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Transcriptional misregulation in cancer D08964 Perampanel 3件: 2, 6, 144
630 GRIA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
631 GRIA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
632 GRIA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D02696 Talampanel 2件: 2, 6
633 GRIA4 4件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08964 Perampanel 3件: 2, 6, 144
634 GRIK1 1件: Neuroactive ligand-receptor interaction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
635 GRIK1 1件: Neuroactive ligand-receptor interaction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
636 GRIK2 1件: Neuroactive ligand-receptor interaction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
637 GRIK2 1件: Neuroactive ligand-receptor interaction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
638 GRIK3 1件: Neuroactive ligand-receptor interaction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
639 GRIK3 1件: Neuroactive ligand-receptor interaction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
640 GRIK4 1件: Neuroactive ligand-receptor interaction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
641 GRIK4 1件: Neuroactive ligand-receptor interaction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
642 GRIK5 1件: Neuroactive ligand-receptor interaction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
643 GRIK5 1件: Neuroactive ligand-receptor interaction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
644 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
645 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
646 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07058 Acamprosate 2件: 6, 206
647 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07283 Esketamine 3件: 2, 4, 70
648 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07441 Amantadine 4件: 6, 8, 13, 127
649 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
650 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
651 GRIN1 7件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D09917 Latrepirdine 1件: 8
652 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
653 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
654 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D07058 Acamprosate 2件: 6, 206
655 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D07283 Esketamine 3件: 2, 4, 70
656 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D07441 Amantadine 4件: 6, 8, 13, 127
657 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
658 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
659 GRIN2A 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D09917 Latrepirdine 1件: 8
660 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
661 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
662 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D07058 Acamprosate 2件: 6, 206
663 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D07283 Esketamine 3件: 2, 4, 70
664 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D07441 Amantadine 4件: 6, 8, 13, 127
665 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
666 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
667 GRIN2B 8件: Ras signaling pathway, Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction, Systemic lupus erythematosus D09917 Latrepirdine 1件: 8
668 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
669 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
670 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07058 Acamprosate 2件: 6, 206
671 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07283 Esketamine 3件: 2, 4, 70
672 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07441 Amantadine 4件: 6, 8, 13, 127
673 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
674 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
675 GRIN2C 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D09917 Latrepirdine 1件: 8
676 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D00775 Riluzole 9件: 2, 3, 5, 8, 13, 17, 18, 203, 206
677 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D03742 Dextromethorphan 11件: 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156
678 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07058 Acamprosate 2件: 6, 206
679 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07283 Esketamine 3件: 2, 4, 70
680 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D07441 Amantadine 4件: 6, 8, 13, 127
681 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08098 Ketamine 8件: 2, 4, 6, 13, 70, 113, 156, 215
682 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D08174 Memantine 8件: 2, 6, 8, 13, 49, 127, 205, 206
683 GRIN2D 5件: Neuroactive ligand-receptor interaction, Spinocerebellar ataxia, Prion disease, Pathways of neurodegeneration - multiple diseases, Nicotine addiction D09917 Latrepirdine 1件: 8
684 NR3C1 1件: Neuroactive ligand-receptor interaction D00088 Hydrocortisone 10件: 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
685 NR3C1 1件: Neuroactive ligand-receptor interaction D00165 Hydrocortisone acetate 1件: 97
686 NR3C1 1件: Neuroactive ligand-receptor interaction D00244 Betamethasone 8件: 2, 28, 46, 65, 83, 90, 96, 235
687 NR3C1 1件: Neuroactive ligand-receptor interaction D00246 Budesonide 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299
688 NR3C1 1件: Neuroactive ligand-receptor interaction D00292 Dexamethasone 22件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299
689 NR3C1 1件: Neuroactive ligand-receptor interaction D00385 Triamcinolone 11件: 35, 46, 53, 56, 70, 90, 96, 107, 162, 226, 298
690 NR3C1 1件: Neuroactive ligand-receptor interaction D00407 Methylprednisolone 46件: 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296
691 NR3C1 1件: Neuroactive ligand-receptor interaction D00472 Prednisolone 42件: 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300
692 NR3C1 1件: Neuroactive ligand-receptor interaction D00473 Prednisone 45件: 2, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 162, 164, 205, 222, 224, 228, 283, 284, 288, 299, 300, 307, 331
693 NR3C1 1件: Neuroactive ligand-receptor interaction D00585 Mifepristone 1件: 75
694 NR3C1 1件: Neuroactive ligand-receptor interaction D00689 Beclomethasone dipropionate 3件: 85, 97, 98
695 NR3C1 1件: Neuroactive ligand-receptor interaction D00690 Mometasone furoate 2件: 98, 162
696 NR3C1 1件: Neuroactive ligand-receptor interaction D00973 Cortisone acetate 1件: 81
697 NR3C1 1件: Neuroactive ligand-receptor interaction D00976 Hydrocortisone cypionate 3件: 6, 81, 83
698 NR3C1 1件: Neuroactive ligand-receptor interaction D00980 Prednisolone acetate 1件: 222
699 NR3C1 1件: Neuroactive ligand-receptor interaction D01272 Clobetasol propionate 2件: 46, 162
700 NR3C1 1件: Neuroactive ligand-receptor interaction D01442 Hydrocortisone succinate 3件: 6, 81, 83
701 NR3C1 1件: Neuroactive ligand-receptor interaction D01703 Ciclesonide 1件: 84
702 NR3C1 1件: Neuroactive ligand-receptor interaction D01708 Fluticasone propionate 2件: 98, 228
703 NR3C1 1件: Neuroactive ligand-receptor interaction D01825 Fluocinolone acetonide 1件: 90
704 NR3C1 1件: Neuroactive ligand-receptor interaction D03671 Deflazacort 2件: 30, 113
705 NR3C1 1件: Neuroactive ligand-receptor interaction D05000 Methylprednisolone hemisuccinate 7件: 13, 49, 50, 51, 53, 97, 211
706 NR3C1 1件: Neuroactive ligand-receptor interaction D07202 Halometasone 1件: 162
707 NR3C1 1件: Neuroactive ligand-receptor interaction D07715 Clobetasol 4件: 39, 46, 51, 162
708 NR3C1 1件: Neuroactive ligand-receptor interaction D07749 Cortisone 1件: 81
709 NR3C1 1件: Neuroactive ligand-receptor interaction D07981 Fluticasone 3件: 98, 228, 299
710 NR3C1 1件: Neuroactive ligand-receptor interaction D08227 Mometasone 2件: 98, 162
711 NR3C1 1件: Neuroactive ligand-receptor interaction D08416 Prednisone acetate 6件: 35, 41, 46, 49, 162, 224
712 NR3C1 1件: Neuroactive ligand-receptor interaction D11000 Vamorolone 2件: 97, 113
713 NR3C1 1件: Neuroactive ligand-receptor interaction D11336 Relacorilant 1件: 75
714 HCRTR1 1件: Neuroactive ligand-receptor interaction D10082 Suvorexant 3件: 5, 6, 13
715 HCRTR2 1件: Neuroactive ligand-receptor interaction D10082 Suvorexant 3件: 5, 6, 13
716 HRH1 1件: Neuroactive ligand-receptor interaction D00270 Chlorpromazine 1件: 254
717 HRH1 1件: Neuroactive ligand-receptor interaction D00300 Diphenhydramine 8件: 11, 13, 49, 51, 70, 86, 222, 256
718 HRH1 1件: Neuroactive ligand-receptor interaction D00364 Loratadine 4件: 13, 46, 89, 98
719 HRH1 1件: Neuroactive ligand-receptor interaction D00454 Olanzapine 2件: 2, 8
720 HRH1 1件: Neuroactive ligand-receptor interaction D00494 Promethazine 1件: 96
721 HRH1 1件: Neuroactive ligand-receptor interaction D03535 Clemastine 1件: 13
722 HRH1 1件: Neuroactive ligand-receptor interaction D03693 Desloratadine 1件: 13
723 HRH1 1件: Neuroactive ligand-receptor interaction D07398 Chlorpheniramine 1件: 14
724 HRH1 1件: Neuroactive ligand-receptor interaction D07402 Levocetirizine 1件: 61
725 HRH1 1件: Neuroactive ligand-receptor interaction D07407 Rupatadine 1件: 46
726 HRH1 1件: Neuroactive ligand-receptor interaction D07662 Cetirizine 4件: 13, 28, 35, 300
727 HRH1 1件: Neuroactive ligand-receptor interaction D07803 Dexchlorpheniramine 2件: 13, 49
728 HRH1 1件: Neuroactive ligand-receptor interaction D07875 Doxepin 1件: 6
729 HRH1 1件: Neuroactive ligand-receptor interaction D07958 Fexofenadine 2件: 13, 46
730 HRH2 1件: Neuroactive ligand-receptor interaction D00295 Cimetidine 2件: 2, 254
731 HRH2 1件: Neuroactive ligand-receptor interaction D00318 Famotidine 6件: 6, 46, 61, 86, 98, 107
732 HRH2 1件: Neuroactive ligand-receptor interaction D00422 Ranitidine 2件: 13, 65
733 HTR1A 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D01164 Aripiprazole 2件: 6, 206
734 HTR1A 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D07593 Buspirone 2件: 6, 51
735 HTR1A 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D09397 Pardoprunox 1件: 6
736 HTR1A 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D09997 Cariprazine 1件: 21
737 HTR1A 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D10184 Vortioxetine 1件: 6
738 HTR1B 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D00415 Zolmitriptan 1件: 6
739 HTR1D 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D00415 Zolmitriptan 1件: 6
740 HTR1D 3件: Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction D07945 Fenfluramine 4件: 140, 144, 145, 149
741 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00270 Chlorpromazine 1件: 254
742 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00274 Cisapride 1件: 13
743 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00283 Clozapine 1件: 6
744 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00426 Risperidone 5件: 8, 156, 179, 187, 206
745 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00454 Olanzapine 2件: 2, 8
746 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D01164 Aripiprazole 2件: 6, 206
747 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D02092 Cisapride 1件: 13
748 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D02666 Iloperidone 1件: 6
749 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D07945 Fenfluramine 4件: 140, 144, 145, 149
750 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D08456 Quetiapine 2件: 6, 13
751 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D08626 Trazodone 1件: 2
752 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D09645 Nelotanserin 1件: 6
753 HTR2A 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D09997 Cariprazine 1件: 21
754 HTR2B 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00270 Chlorpromazine 1件: 254
755 HTR2B 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00454 Olanzapine 2件: 2, 8
756 HTR2B 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D02666 Iloperidone 1件: 6
757 HTR2B 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D08626 Trazodone 1件: 2
758 HTR2C 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00270 Chlorpromazine 1件: 254
759 HTR2C 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00283 Clozapine 1件: 6
760 HTR2C 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00454 Olanzapine 2件: 2, 8
761 HTR2C 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D02578 Agomelatine 1件: 6
762 HTR2C 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D02666 Iloperidone 1件: 6
763 HTR2C 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D07945 Fenfluramine 4件: 140, 144, 145, 149
764 HTR2C 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D08626 Trazodone 1件: 2
765 HTR4 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00274 Cisapride 1件: 13
766 HTR4 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D02092 Cisapride 1件: 13
767 HTR4 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D08236 Mosapride 1件: 96
768 HTR4 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D09205 Prucalopride 3件: 13, 51, 96
769 HTR4 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D09693 Velusetrag 1件: 99
770 HTR6 2件: Neuroactive ligand-receptor interaction, Serotonergic synapse D00454 Olanzapine 2件: 2, 8
771 LEPR 2件: Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease D05014 Metreleptin 1件: 265
772 MC1R 1件: Neuroactive ligand-receptor interaction D10511 Afamelanotide 3件: 159, 161, 254
773 MC2R 1件: Neuroactive ligand-receptor interaction D00146 Corticotropin 12件: 2, 13, 14, 46, 49, 50, 66, 75, 81, 84, 145, 222
774 MC2R 1件: Neuroactive ligand-receptor interaction D00284 Tetracosactide 5件: 78, 83, 113, 145, 222
775 MC4R 1件: Neuroactive ligand-receptor interaction D11927 Setmelanotide 2件: 202, 265
776 MTNR1A 1件: Neuroactive ligand-receptor interaction D02578 Agomelatine 1件: 6
777 MTNR1A 1件: Neuroactive ligand-receptor interaction D02689 Ramelteon 3件: 6, 8, 46
778 MTNR1A 1件: Neuroactive ligand-receptor interaction D08170 Melatonin 12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202
779 MTNR1A 1件: Neuroactive ligand-receptor interaction D09388 Tasimelteon 1件: 202
780 MTNR1B 1件: Neuroactive ligand-receptor interaction D02578 Agomelatine 1件: 6
781 MTNR1B 1件: Neuroactive ligand-receptor interaction D02689 Ramelteon 3件: 6, 8, 46
782 MTNR1B 1件: Neuroactive ligand-receptor interaction D08170 Melatonin 12件: 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202
783 MTNR1B 1件: Neuroactive ligand-receptor interaction D09388 Tasimelteon 1件: 202
784 OPRD1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D05111 Nalmefene 1件: 6
785 OPRD1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D05113 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226
786 OPRD1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D05312 Oxycodone 5件: 6, 13, 70, 226, 298
787 OPRD1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D08144 Loperamide 2件: 13, 97
788 OPRD1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D08246 Nalbuphine 1件: 85
789 OPRD1 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D08249 Naloxone 2件: 6, 226
790 OPRK1 1件: Neuroactive ligand-receptor interaction D00838 Dezocine 1件: 46
791 OPRK1 1件: Neuroactive ligand-receptor interaction D05111 Nalmefene 1件: 6
792 OPRK1 1件: Neuroactive ligand-receptor interaction D05113 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226
793 OPRK1 1件: Neuroactive ligand-receptor interaction D05312 Oxycodone 5件: 6, 13, 70, 226, 298
794 OPRK1 1件: Neuroactive ligand-receptor interaction D07132 Buprenorphine 2件: 46, 70
795 OPRK1 1件: Neuroactive ligand-receptor interaction D08144 Loperamide 2件: 13, 97
796 OPRK1 1件: Neuroactive ligand-receptor interaction D08246 Nalbuphine 1件: 85
797 OPRK1 1件: Neuroactive ligand-receptor interaction D08249 Naloxone 2件: 6, 226
798 OPRK1 1件: Neuroactive ligand-receptor interaction D08639 Trimebutine 1件: 51
799 OPRM1 1件: Neuroactive ligand-receptor interaction D00320 Fentanyl 3件: 46, 70, 215
800 OPRM1 1件: Neuroactive ligand-receptor interaction D00838 Dezocine 1件: 46
801 OPRM1 1件: Neuroactive ligand-receptor interaction D05111 Nalmefene 1件: 6
802 OPRM1 1件: Neuroactive ligand-receptor interaction D05113 Naltrexone 13件: 6, 10, 13, 40, 41, 42, 43, 44, 45, 46, 96, 97, 226
803 OPRM1 1件: Neuroactive ligand-receptor interaction D05312 Oxycodone 5件: 6, 13, 70, 226, 298
804 OPRM1 1件: Neuroactive ligand-receptor interaction D05938 Sufentanil 2件: 70, 280
805 OPRM1 1件: Neuroactive ligand-receptor interaction D07132 Buprenorphine 2件: 46, 70
806 OPRM1 1件: Neuroactive ligand-receptor interaction D07831 Dihydrocodeine 1件: 310
807 OPRM1 1件: Neuroactive ligand-receptor interaction D08047 Hydromorphone 1件: 70
808 OPRM1 1件: Neuroactive ligand-receptor interaction D08144 Loperamide 2件: 13, 97
809 OPRM1 1件: Neuroactive ligand-receptor interaction D08233 Morphine 5件: 36, 46, 70, 85, 86
810 OPRM1 1件: Neuroactive ligand-receptor interaction D08246 Nalbuphine 1件: 85
811 OPRM1 1件: Neuroactive ligand-receptor interaction D08249 Naloxone 2件: 6, 226
812 OPRM1 1件: Neuroactive ligand-receptor interaction D08323 Oxymorphone 1件: 70
813 OPRM1 1件: Neuroactive ligand-receptor interaction D08473 Remifentanil 2件: 6, 70
814 OPRM1 1件: Neuroactive ligand-receptor interaction D08623 Tramadol 5件: 46, 70, 78, 226, 271
815 OPRM1 1件: Neuroactive ligand-receptor interaction D08639 Trimebutine 1件: 51
816 OXTR 2件: Neuroactive ligand-receptor interaction, Oxytocin signaling pathway D00089 Oxytocin 7件: 6, 72, 127, 168, 193, 206, 226
817 OXTR 2件: Neuroactive ligand-receptor interaction, Oxytocin signaling pathway D03008 Atosiban 1件: 118
818 P2RX3 2件: Neuroactive ligand-receptor interaction, Taste transduction D11349 Gefapixant 2件: 85, 226
819 PLG 2件: Neuroactive ligand-receptor interaction, Staphylococcus aureus infection D00160 Aminocaproic acid 1件: 70
820 PLG 2件: Neuroactive ligand-receptor interaction, Staphylococcus aureus infection D01136 Tranexamic acid 7件: 46, 70, 215, 227, 274, 288, 299
821 S1PR5 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10905 Amiselimod 1件: 97
822 S1PR5 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10930 Etrasimod 3件: 96, 97, 98
823 S1PR5 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10968 Ozanimod 3件: 13, 96, 97
824 S1PR5 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D11460 Siponimod 2件: 13, 50
825 AVPR1A 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D00101 Vasopressin 1件: 210
826 AVPR1A 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D06672 Terlipressin 1件: 299
827 AVPR1A 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D07748 Conivaptan 1件: 86
828 AVPR1B 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D00101 Vasopressin 1件: 210
829 AVPR1B 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D06672 Terlipressin 1件: 299
830 AVPR2 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D00101 Vasopressin 1件: 210
831 AVPR2 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D00291 Desmopressin 6件: 6, 64, 72, 75, 225, 288
832 AVPR2 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D01213 Tolvaptan 4件: 67, 72, 86, 225
833 AVPR2 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D04752 Lixivaptan 1件: 67
834 AVPR2 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D06672 Terlipressin 1件: 299
835 AVPR2 3件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption D07748 Conivaptan 1件: 86
836 CHRNA9 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
837 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00225 Alprazolam 2件: 8, 75
838 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00280 Clonazepam 1件: 6
839 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00293 Diazepam 3件: 46, 155, 298
840 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00365 Lorazepam 1件: 36
841 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00537 Topiramate 6件: 6, 97, 140, 144, 156, 193
842 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00549 Propofol 9件: 6, 21, 22, 34, 46, 70, 75, 98, 296
843 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00550 Midazolam 12件: 2, 3, 6, 13, 21, 46, 70, 96, 97, 272, 298, 299
844 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D00697 Flumazenil 5件: 6, 13, 17, 18, 206
845 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01253 Clobazam 2件: 140, 144
846 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D01372 Zopiclone 1件: 6
847 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D02624 Eszopiclone 3件: 6, 13, 46
848 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04282 Gaboxadol 2件: 201, 206
849 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D04300 Ganaxolone 4件: 145, 152, 158, 206
850 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D07784 Delorazepam 3件: 6, 46, 97
851 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D08690 Zolpidem 3件: 5, 6, 46
852 GABRQ 3件: Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Nicotine addiction D11149 Brexanolone 1件: 205
853 PRL 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Prolactin signaling pathway D00987 Cabergoline 3件: 6, 74, 75
854 PRL 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Prolactin signaling pathway D01348 Terguride 2件: 51, 86
855 PRL 3件: Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Prolactin signaling pathway D03165 Bromocriptine 2件: 6, 74
856 CHRNA10 1件: Neuroactive ligand-receptor interaction D03365 Nicotine 3件: 6, 13, 84
857 PTAFR 2件: Neuroactive ligand-receptor interaction, Staphylococcus aureus infection D07407 Rupatadine 1件: 46
858 PTGDR 1件: Neuroactive ligand-receptor interaction D01128 Ramatroban 1件: 13
859 PTGER1 2件: Neuroactive ligand-receptor interaction, Pathways in cancer D00180 Alprostadil 2件: 51, 70
860 PTGER1 2件: Neuroactive ligand-receptor interaction, Pathways in cancer D02722 Limaprost 1件: 70
861 PTGER2 3件: Neuroactive ligand-receptor interaction, Renin secretion, Pathways in cancer D00419 Misoprostol 3件: 46, 70, 271
862 PTGER3 3件: Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Pathways in cancer D00419 Misoprostol 3件: 46, 70, 271
863 PTGER4 3件: Neuroactive ligand-receptor interaction, Renin secretion, Pathways in cancer D00419 Misoprostol 3件: 46, 70, 271
864 PTGFR 2件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction D06274 Tafluprost 1件: 299
865 PTGFR 2件: Phospholipase D signaling pathway, Neuroactive ligand-receptor interaction D08661 Unoprostone 1件: 90
866 PTGIR 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation D00106 Epoprostenol 1件: 86
867 PTGIR 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation D01385 Ibudilast 2件: 2, 13
868 PTGIR 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation D02720 Beraprost 1件: 86
869 PTGIR 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation D02721 Iloprost 4件: 51, 84, 85, 86
870 PTGIR 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation D06213 Treprostinil 6件: 51, 84, 85, 86, 88, 210
871 PTGIR 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation D09994 Selexipag 5件: 51, 70, 84, 86, 88
872 PTGIR 3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation D10725 Ralinepag 1件: 86
873 PTH1R 2件: Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action D05364 Parathyroid hormone 4件: 65, 70, 235, 326
874 PTH1R 2件: Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action D06078 Teriparatide 7件: 46, 65, 68, 70, 71, 235, 274
875 PTH2R 1件: Neuroactive ligand-receptor interaction D05364 Parathyroid hormone 4件: 65, 70, 235, 326
876 SSTR1 1件: Neuroactive ligand-receptor interaction D07431 Somatostatin 2件: 67, 78
877 SSTR1 1件: Neuroactive ligand-receptor interaction D10147 Pasireotide 3件: 67, 74, 75
878 SSTR2 1件: Neuroactive ligand-receptor interaction D00442 Octreotide 7件: 67, 75, 84, 85, 89, 193, 227
879 SSTR2 1件: Neuroactive ligand-receptor interaction D07431 Somatostatin 2件: 67, 78
880 SSTR2 1件: Neuroactive ligand-receptor interaction D10147 Pasireotide 3件: 67, 74, 75
881 SSTR3 1件: Neuroactive ligand-receptor interaction D07431 Somatostatin 2件: 67, 78
882 SSTR3 1件: Neuroactive ligand-receptor interaction D10147 Pasireotide 3件: 67, 74, 75
883 SSTR4 1件: Neuroactive ligand-receptor interaction D07431 Somatostatin 2件: 67, 78
884 SSTR5 1件: Neuroactive ligand-receptor interaction D07431 Somatostatin 2件: 67, 78
885 SSTR5 1件: Neuroactive ligand-receptor interaction D10147 Pasireotide 3件: 67, 74, 75
886 TACR1 1件: Neuroactive ligand-receptor interaction D09378 Serlopitant 1件: 36
887 TACR1 1件: Neuroactive ligand-receptor interaction D09650 Orvepitant 1件: 85
888 TBXA2R 2件: Neuroactive ligand-receptor interaction, Platelet activation D01128 Ramatroban 1件: 13
889 TBXA2R 2件: Neuroactive ligand-receptor interaction, Platelet activation D01896 Cilostazol 3件: 46, 51, 70
890 TBXA2R 2件: Neuroactive ligand-receptor interaction, Platelet activation D04500 Ifetroban 2件: 85, 113
891 THRA 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway D07214 Tiratricol 2件: 78, 139
892 THRA 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway D08125 Levothyroxine 5件: 19, 49, 78, 80, 222
893 THRA 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway D08128 Liothyronine 4件: 13, 78, 210, 212
894 THRB 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway D07214 Tiratricol 2件: 78, 139
895 THRB 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway D08125 Levothyroxine 5件: 19, 49, 78, 80, 222
896 THRB 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway D08128 Liothyronine 4件: 13, 78, 210, 212
897 THRB 2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway D09381 Sobetirome 1件: 20
898 C3 9件: Neuroactive ligand-receptor interaction, Phagosome, Neutrophil extracellular trap formation, Shigellosis, Pertussis, Staphylococcus aureus infection, Tuberculosis, Viral carcinogenesis, Systemic lupus erythematosus D11613 Pegcetacoplan 4件: 2, 61, 62, 222
899 TRHR 1件: Neuroactive ligand-receptor interaction D00176 Protirelin 1件: 80
900 C5 7件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Prion disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus D03940 Eculizumab 7件: 11, 13, 14, 61, 62, 109, 222
901 C5 7件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Prion disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus D11054 Ravulizumab 7件: 2, 11, 13, 50, 62, 66, 109
902 C5 7件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Prion disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus D11473 Nomacopan 3件: 62, 109, 162
903 C5 7件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Prion disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus D11477 Pozelimab 2件: 11, 62
904 C5 7件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Prion disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus D11696 Crovalimab 2件: 62, 109
905 C5 7件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Prion disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus D11838 Vilobelimab 3件: 43, 44, 269
906 C5 7件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Regulation of actin cytoskeleton, Prion disease, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus D12357 Zilucoplan 3件: 2, 11, 62
907 C5AR1 3件: Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection D11093 Avacopan 3件: 43, 44, 222
908 TRPV1 1件: Neuroactive ligand-receptor interaction D00250 Capsaicin 3件: 6, 86, 226
909 CALCA 2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction D11055 Fremanezumab 2件: 124, 226
910 S1PR4 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10905 Amiselimod 1件: 97
911 S1PR4 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10930 Etrasimod 3件: 96, 97, 98
912 S1PR4 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10968 Ozanimod 3件: 13, 96, 97
913 CCKBR 1件: Neuroactive ligand-receptor interaction D01818 Proglumide 1件: 298
914 CHRNA6 2件: Neuroactive ligand-receptor interaction, Nicotine addiction D03365 Nicotine 3件: 6, 13, 84
915 S1PR2 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10905 Amiselimod 1件: 97
916 S1PR2 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10930 Etrasimod 3件: 96, 97, 98
917 S1PR2 2件: Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction D10968 Ozanimod 3件: 13, 96, 97
918 GLP2R 1件: Neuroactive ligand-receptor interaction D06053 Teduglutide 1件: 96
919 GABBR2 2件: Neuroactive ligand-receptor interaction, Taste transduction D00241 Baclofen 8件: 2, 10, 13, 18, 65, 70, 149, 206
920 GABBR2 2件: Neuroactive ligand-receptor interaction, Taste transduction D08861 Arbaclofen Placarbil 1件: 13
921 GABBR2 2件: Neuroactive ligand-receptor interaction, Taste transduction D09791 Arbaclofen 2件: 13, 206
922 GABBR2 2件: Neuroactive ligand-receptor interaction, Taste transduction D12240 Valiloxybate 1件: 6